Investigation of the effect of interalipid on aluminum phosphide poisoning

Phase 2

• Conditions: Aluminium phosphide poisoning.; Toxic effect of phosphorus and its compounds, intentional self-harm; T57.1X2

• Registration Number: IRCT20220618055207N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

aluminum phosphide poisoning
Metabolic acidosis (bicarbonate less than 14) during the first 6 hours

Exclusion Criteria

Dissatisfaction of patients
simultaneous poisoning (multidrug toxicity)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Heart rate, systolic blood pressure, acidosis and arterial blood pH, death. Timepoint: At the beginning of the study and 24 hours after the start of the intervention. Method of measurement: Vital Sign Monitor in icu.